145 related articles for article (PubMed ID: 3532540)
41. Depletion of T cells from bone marrow grafts with soybean agglutinin and sheep red blood cells for prevention of graft-versus-host disease.
Verdonck LF; Dekker AW; van Heugten H; van Kempen ML; Punt K; de Gast GC
Haematol Blood Transfus; 1987; 30():563-6. PubMed ID: 3305219
[No Abstract] [Full Text] [Related]
42. Bone marrow transplantation in 26 patients with Wiskott-Aldrich syndrome from a single center.
Ozsahin H; Le Deist F; Benkerrou M; Cavazzana-Calvo M; Gomez L; Griscelli C; Blanche S; Fischer A
J Pediatr; 1996 Aug; 129(2):238-44. PubMed ID: 8765621
[TBL] [Abstract][Full Text] [Related]
43. Graft vs graft reaction resulting in the elimination of maternal cells in a SCID patient with maternofetal GVHd after an HLA identical bone marrow transplantation.
Le Deist F; Raffoux C; Griscelli C; Fischer A
J Immunol; 1987 Jan; 138(2):423-7. PubMed ID: 3540121
[TBL] [Abstract][Full Text] [Related]
44. Comparison of three techniques for the ex vivo elimination of T cells from human bone marrow.
Blazar BR; Quinones RR; Heinitz KJ; Sevenich EA; Filipovich AH
Exp Hematol; 1985 Feb; 13(2):123-8. PubMed ID: 3882442
[TBL] [Abstract][Full Text] [Related]
45. [Bone marrow transplantation in the primary immunodeficiencies].
Madero López L; Villa Alcázar M
Sangre (Barc); 1999 Apr; 44(2):135-41. PubMed ID: 10382323
[No Abstract] [Full Text] [Related]
46. In vitro analysis of donor bone marrow following monoclonal antibody treatment for the prevention of acute graft versus host disease.
Kohler PC; Erickson C; Finlay JL; Trigg ME; Edwards B; Hong R; Hank JA; Billing R; Bozdech M; Sondel PM
Cancer Res; 1986 Oct; 46(10):5413-8. PubMed ID: 3530439
[TBL] [Abstract][Full Text] [Related]
47. Development of immunity in human severe primary T cell deficiency following haploidentical bone marrow stem cell transplantation.
Buckley RH; Schiff SE; Sampson HA; Schiff RI; Markert ML; Knutsen AP; Hershfield MS; Huang AT; Mickey GH; Ward FE
J Immunol; 1986 Apr; 136(7):2398-407. PubMed ID: 2869085
[TBL] [Abstract][Full Text] [Related]
48. Development of tolerance after haplocompatible T-depleted bone marrow transplantation.
Merino A; Dror Y; Benkerrou M; Colombe BW; Cowan MJ
Bone Marrow Transplant; 1993 Nov; 12(5):483-8. PubMed ID: 8298559
[TBL] [Abstract][Full Text] [Related]
49. Dissociation between onset of natural killer E-rosette forming cells and of T3-positive cells following HLA-mismatched T cell depleted bone marrow transplantation.
De Villartay JP; Le Deist F; Griscelli C; Fischer A
Clin Exp Immunol; 1987 Feb; 67(2):406-14. PubMed ID: 3301094
[TBL] [Abstract][Full Text] [Related]
50. Bone marrow transplantation for the treatment of immune deficiency states.
Lenarsky C; Parkman R
Bone Marrow Transplant; 1990 Dec; 6(6):361-9. PubMed ID: 1965792
[TBL] [Abstract][Full Text] [Related]
51. Marrow transplantation for congenital disorders.
O'Reilly RJ; Brochstein J; Dinsmore R; Kirkpatrick D
Semin Hematol; 1984 Jul; 21(3):188-221. PubMed ID: 6379881
[No Abstract] [Full Text] [Related]
52. Treatment of immunodeficiency diseases by organ transplantation.
Parkman R
Prog Clin Immunol; 1977; 3():85-102. PubMed ID: 17139
[No Abstract] [Full Text] [Related]
53. Effect of selective T cell depletion of host and/or donor bone marrow on lymphopoietic repopulation, tolerance, and graft-vs-host disease in mixed allogeneic chimeras (B10 + B10.D2----B10).
Ildstad ST; Wren SM; Bluestone JA; Barbieri SA; Stephany D; Sachs DH
J Immunol; 1986 Jan; 136(1):28-33. PubMed ID: 2933464
[TBL] [Abstract][Full Text] [Related]
54. Absence of demonstrable suppressor cell activity in a severe combined immunodeficiency patient with a sustained engraftment of DR-positive maternal T cells.
Pollack MS; Kapoor N; Sorell M; Morishima Y; Dupont B; O'Reilly RJ
Transplant Proc; 1981 Mar; 13(1 Pt 1):270-2. PubMed ID: 6455792
[No Abstract] [Full Text] [Related]
55. Bone marrow transplanation for severe combined immunodeficiency with the HL-A-incompatible but MLC-identical mother as a donor.
Neithammer D; Goldmann SF; Haas RJ; Dietrich M; Flad HD; Fliedner TM; Kleihauer E
Transplant Proc; 1976 Dec; 8(4):623-8. PubMed ID: 11594
[No Abstract] [Full Text] [Related]
56. Nature of reconstitution with histoincompatible maternal marrow in a case of severe combined immunodeficiency with graft-versus-host disease following maternofetal transfusion.
Niethammer D; Goldmann SF; Flad HD; Bienzle U; Dieterle U; Haas RJ; Heymer B; Meigel W; Belohradsky BH; Kleihauer E
Clin Immunol Immunopathol; 1981 Mar; 18(3):387-401. PubMed ID: 7018767
[No Abstract] [Full Text] [Related]
57. Deficiency of NK activity of HNK-1+ cells after transplantation of fetal thymus and liver or haploidentical soybean agglutinin-treated marrow cells in two severe combined immunodeficiency patients.
Gotoh YI; Yamaguchi Y; Minegishi M; Konno T; Tada K
Clin Exp Immunol; 1985 Sep; 61(3):608-13. PubMed ID: 3907904
[TBL] [Abstract][Full Text] [Related]
58. Marrow transplantation from human leukocyte antigen-identical or haploidentical donors for correction of Wiskott-Aldrich syndrome.
Brochstein JA; Gillio AP; Ruggiero M; Kernan NA; Emanuel D; Laver J; Small T; O'Reilly RJ
J Pediatr; 1991 Dec; 119(6):907-12. PubMed ID: 1960605
[TBL] [Abstract][Full Text] [Related]
59. Bone-marrow transplantation for immunodeficiencies and osteopetrosis: European survey, 1968-1985.
Fischer A; Griscelli C; Friedrich W; Kubanek B; Levinsky R; Morgan G; Vossen J; Wagemaker G; Landais P
Lancet; 1986 Nov; 2(8515):1080-4. PubMed ID: 2877234
[TBL] [Abstract][Full Text] [Related]
60. CD6+ T cell depleted allogeneic bone marrow transplantation from genotypically HLA nonidentical related donors.
Soiffer RJ; Mauch P; Fairclough D; Alyea E; Anderson K; Fisher D; Freedman A; Bartlett-Pandite L; Robertson M; Schlossman R; Gollob J; Marcus K; Murray C; Kuhlman C; Freeman A; Nadler L; Ritz J
Biol Blood Marrow Transplant; 1997 Apr; 3(1):11-7. PubMed ID: 9209736
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
